Sagimet Biosciences Inc - Series A — Dividend History & Yield (NASDAQ:SGMT) | MetaTrader

Open full chart

Financials

Overview Finanzbericht Statistics Dividends

Quarterly Annual

Dividends per share —— — Dividend yield % —— — Payout ratio % —— —

Nachrichten

Sagimet-Aktie legt nach positiven Phase-3-Sicherheitsdaten für Akne-Wirkstoff zu

Sagimet stock rises after positive Phase 3 safety data for acne drug

Ascletis reports positive long-term safety data for acne drug denifanstat

Sagimet: Positive Denifanstat Combination PK Data Could Lead To Untapped Market (SGMT)

Sagimet reports positive Phase 1 results for MASH combination therapy

Tracking Baker Brothers Portfolio – Q3 2025 Update (NASDAQ:INCY)

Sagimet Biosciences executive chairman sells $290k in shares

Sagimet Biosciences: Citizens erhöht Kursziel auf 35 US-Dollar

Sagimet Biosciences stock price target raised to $35 by Citizens

Sagimet: Akne-Wirkstoff Denifanstat erreicht alle Endpunkte in Phase-3-Studie in China

Denifanstat meets all endpoints in phase 3 acne trial in China

This Visa Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - First Solar (NASDAQ:FSLR), Klaviyo (NYSE:KVYO)